APA (7th ed.) Citation

NH, L., S, J., WJ, M., SZ, G., DJ, S., AV, D., & JB, Y. (2016). Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. Journal of the National Cancer Institute, 109(6), . https://doi.org/10.1093/jnci/djw281

Chicago Style (17th ed.) Citation

NH, Lester-Coll, Johnson S, Magnuson WJ, Goldhaber SZ, Sher DJ, D'Amico AV, and Yu JB. "Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer." Journal of the National Cancer Institute 109, no. 6 (2016). https://doi.org/10.1093/jnci/djw281.

MLA (9th ed.) Citation

NH, Lester-Coll, et al. "Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer." Journal of the National Cancer Institute, vol. 109, no. 6, 2016, https://doi.org/10.1093/jnci/djw281.